VERACYTE INC

For the period ended Dec 31, 2024. Filed Feb 28, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

VCYT$24.06-7.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, 202 and

Consolidated Balance Sheets

(in thousands, except share and par value amounts)

	As of December 31,
	2024	2023
Assets
Current assets:
Cash and cash equivalents	$239,087	$216,454
Short-term investments	50,354	—
Accounts receivable	46,525	40,378
Supplies and inventory	21,750	16,128
Prepaid expenses and other current assets	14,551	12,661
Total current assets	372,267	285,621
Property, plant and equipment, net	22,953	20,584
Right-of-use assets, operating leases	48,189	10,277
Intangible assets, net	102,301	88,593
Goodwill	745,800	702,984
Restricted cash	1,544	876
Other assets	6,981	5,971
Total assets	$1,300,035	$1,114,906
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$8,634	$12,943
Accrued liabilities	43,826	38,427
Current portion of deferred revenue	1,673	2,008
Current portion of acquisition-related contingent consideration	16,981	2,657
Current portion of operating lease liabilities	7,500	5,105
Current portion of other liabilities	19	101
Total current liabilities	78,633	61,241
Deferred tax liability	1,227	734
Acquisition-related contingent consideration, net of current portion	561	518
Operating lease liabilities, net of current portion	43,237	7,525
Other liabilities	411	786
Total liabilities	124,069	70,804
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and 2023	—	—
Common stock, $0.001 par value; 125,000,000 shares authorized, 77,772,678 and 73,264,738 shares issued and outstanding as of December 31, 2024 and 2023, respectively	78	73
Additional paid-in capital	1,655,961	1,536,168
Accumulated deficit	(443,983)	(468,121)
Accumulated other comprehensive loss	(36,090)	(24,018)
Total stockholders' equity	1,175,966	1,044,102
Total liabilities and stockholders' equity	$1,300,035	$1,114,906

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.